Literature DB >> 9145486

Computerized delivery control--a useful and safe complement to the type and screen compatibility testing.

J Säfwenberg1, C F Högman, B Cassemar.   

Abstract

OBJECTIVES: Faster and less labor-intensive crossmatching procedures are needed, but they must be as safe as the traditional antiglobulin method. We present twelve years' experience with a procedure involving antibody screening, blood group checks, and computerized delivery control (ABCD test).
METHODS: We use a computer for validation and printing documents and declaring compatibility between patient and blood component, based on screening results and earlier-recorded data about the patient.
RESULTS: Of 257,400 units transfused during the period, 90% were declared compatible through the ABCD procedure, and 10% had to be crossmatched. We observed no hemolytic transfusion complications due to a failure of the procedure to detect red cell alloantibodies. Labor in the testing laboratory was reduced by 65% compared to a previous crossmatching period. Fewer blood units were returned unused.
CONCLUSION: The procedure using a computerized system as a guard against human mistakes has been found to be safe and reliable and is now widely used in Sweden.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9145486     DOI: 10.1046/j.1423-0410.1997.7230162.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  3 in total

Review 1.  Is it time to give up the crossmatch?

Authors:  J P Wallis
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

2.  Blood utilization and quality indicators at a university hospital in the Eastern Province of Saudi Arabia.

Authors:  Hwazen Shash; Rana Alabdulqader; Lama Alshehri; Norah Alkathery; Rozanna Al-Abdulrahman; Shatha Alahmed; Dalal Bubshait; Suzan AlKhater; Awatif Al-Nafie
Journal:  PLoS One       Date:  2022-04-22       Impact factor: 3.752

3.  Virtual blood bank.

Authors:  Kit Fai Wong
Journal:  J Pathol Inform       Date:  2011-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.